Home > SWOT Analysis > Crucell (CRXLY) SWOT Analysis





Crucell (CRXLY) SWOT Analysis Profile

Crucell N.V. is a biopharmaceutical company focused on developing and producing products to combat infectious diseases in three distinct areas: pediatric, travel and endemic, and respiratory. Crucells product development programs include vaccines against yellow fever, influenza, human immunodeficiency virus (HIV), malaria, tuberculosis, human monoclonal antibodies against rabies, H5N1 antibodies, pandemic influenza virus, as well as blood coagulation factors. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 1

Threats + Weaknesses = 0

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties. The ability to capitalize on opportunities get rewarded with higher profits and lower costs. A good defense against threats lowers the risks that profits will decrease. Maintaining strengths can help maintain high profits and low costs.